CCSER2 pseudogene 1 (CCSER2P1)

CCSER2 pseudogene 1 (CCSER2P1) is classified as a pseudogene, meaning it is a DNA sequence similar to the CCSER2 protein-coding gene but typically does not produce a functional protein product. Pseudogenes often arise from duplication or mutation events and can regulate their parental genes via non-coding RNA transcripts, some of which may play a role in gene expression and disease processes. However, there is no evidence that CCSER2P1 is a therapeutic target, nor are there documented biological or pharmacological interventions involving this pseudogene. While various pseudogenes are increasingly recognized for their capacity to impact regulatory networks or disease phenotypes (e.g., as miRNA decoys or regulators in cancer), CCSER2P1’s function, relevance, or mechanisms remain uncharacterized in the published literature. CCSER2P1 is a non-functional pseudogene not considered a therapeutic target. It has no known protein product, drug interactions, disease-modifying roles, or biomarker status. It is properly classified as a pseudogene and should not be included in lists of receptors, enzymes, transporters, or other molecular targets for therapy. Its designation as a pseudogene indicates lack of a protein product and direct physiological or disease-modifying function. If a drug target is sought, the parental gene CCSER2 (Coiled-Coil Serine Rich Protein 2) may be more relevant, but CCSER2P1 itself is not druggable or actionable.

Other names

CCSER2P1CCSER2 pseudogene 1

Not applicable (non-coding pseudogene; no drug-target mechanism defined)